JNJ

Johnson & Johnson: A Dividend 'King' With A Bright Future
Seeking Alpha
Sat, 01/26/13 - 11:56 am
JNJ
J&J shops feminine products business - WSJ
Reuters
Sat, 01/26/13 - 11:55 am
JNJ
Women's Health
J&J Study Predicted 37% Hip-Failure Rate
Bloomberg
Wed, 01/23/13 - 10:35 am
JNJ
hip implants
J&J to Explore Options for Its Ortho Clinical Diagnostics Unit
Bloomberg
Tue, 01/22/13 - 11:47 am
JNJ
Ortho
M&A
Johnson & Johnson Beats Forecast, but 2013 View Lags Expectations
CNBC
Tue, 01/22/13 - 10:41 am
JNJ
earnings
A Look At 5 Healthcare Giants' Pre-Q4 2012 Earnings Releases
Seeking Alpha
Tue, 01/22/13 - 10:40 am
Intuitive Surgical
Merck
JNJ
Pfizer
Amgen
earnings
Johnson & Johnson At Multi-Year Highs Ahead Of 4Q Earnings
Seeking Alpha
Mon, 01/21/13 - 10:51 am
earnings
JNJ
4 Can't-Miss Health-Care Events This Week
Motley Fool
Mon, 01/21/13 - 10:48 am
Impax Labs
GSK
Rytary
Parkinson's Disease
JNJ
earnings
Intuitive Surgical
Johnson and Johnson's Earnings Should Confirm What a Great Company it Is
Motley Fool
Wed, 01/16/13 - 09:06 am
JNJ
earnings
Johnson & Johnson In 2013: New Revenue Sources And Old OTC Troubles Winding Down
Seeking Alpha
Wed, 01/16/13 - 07:56 am
JNJ
recalls
Can J&J Get Its Diabetes Drug Past the Safety-First FDA?
Motley Fool
Mon, 01/14/13 - 12:00 pm
JNJ
diabetes
FDA
canagliflozin
1 Great Dividend You Can Buy Right Now
Motley Fool
Sat, 01/12/13 - 11:17 am
JNJ
Can J&J Get Its Diabetes Drug Past the Safety-First FDA?
Motley Fool
Sat, 01/12/13 - 11:05 am
JNJ
canagliflozin
diabetes
type 2 diabetes
J&J's Prostate Cancer Drug Zytiga Approved for Earlier Use in EU
Motley Fool
Sat, 01/12/13 - 11:04 am
JNJ
Zytiga
prostate cancer
4 Healthcare Stock Stories for Investor Wellbeing
Wall Street Cheat Street
Sat, 01/12/13 - 10:59 am
JNJ
Telik
AbbVie
Pfizer
J&J Failed to Warn of Vaginal Mesh Risks, Lawyer Says
Bloomberg
Fri, 01/11/13 - 11:40 am
JNJ
vaginal mesh
FDA Panel Backs Novel Diabetes Pill From J&J
Motley Fool
Fri, 01/11/13 - 11:38 am
FDA
advisory panels
JNJ
diabetes
canagliflozin
J&J Diabetes Drug Faces Questions at FDA Advisory Panel
Motley Fool
Thu, 01/10/13 - 09:49 am
diabetes
FDA
JNJ
advisory panel
canagliflozin
Should Any Big Pharma Buy Bausch & Lomb?
Motley Fool
Thu, 01/10/13 - 09:48 am
M&A
Bausch & Lomb
Pfizer
Sanofi
JNJ
Abbott
Merck
4 Biotechnology Stocks With Upcoming Catalysts
Seeking Alpha
Wed, 01/9/13 - 10:06 am
Vivus
Peregrine Pharmaceuticals
JNJ
Cellceutix

Pages